N&O Index Card
Subject/Name: Burroughs Wellcome Company
Article(s) Referenced In:
- Burroughs Wellcome stock rides waves of hope - Ja 18 87 1I
- AZT research focus shifts to varied results - Ja 26 87 1
- Company now can sell AZT; Burroughs Wellcome to market AIDS drug - Mr 21 87 1
- Company sets AZT distribution system - Mr 24 87 18C
- Epidemic of delays cited in AIDS drug tests; Experts: Burroughs Wellcome partly to blame - Ap 12 87 1
- RTP drug firms thrive - Ap 12 87 1I
- Anti-depressant boosts sex drive; But Burroughs Wellcome won't sell pill as aid to ailing libidos - Ap 22 87 1
- AZT cost has not increased, firm says - Ap 23 87 24C
- Wellcome likely to buy Sirrine's building in RTP - Au 22 87 8B
- Wellcome signs pact to market new drug (Hytrin) - Au 26 87 6B
- AIDS victims to find AZT easier to get - Se 12 87 2C
- Burroughs Wellcome to explain AZT pricing - No 25 87 16C
- Drug firm will cut AZT price; Burroughs Wellcome says cut, suit unrelated - De 15 87 1
See a typo in our data? Let us know and we'll fix it.
Places you might find this article:
Search For This Topic
Help us correct this text for future researchers.
Type your transcription below – don't worry about formatting. Please include the line number you are correcting.
Thank you!